American International Group’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-24
Closed -$145 3281
2021
Q1
$145 Buy
24
+1
+4% +$7.25K ﹤0.01% 2531
2020
Q4
$133 Sell
23
-1
-4% -$6.28K ﹤0.01% 2506
2020
Q3
$144K Buy
24
+6
+33% +$35K ﹤0.01% 2326
2020
Q2
$113K Buy
18
+10
+125% +$67.7K ﹤0.01% 2461
2020
Q1
$74K Buy
8
+5
+167% +$78.4K ﹤0.01% 2491
2019
Q4
$45K Hold
3
﹤0.01% 2907
2019
Q3
$44K Hold
3
﹤0.01% 2922
2019
Q2
$59K Buy
3
+1
+50% +$24.7K ﹤0.01% 2904
2019
Q1
$49K Hold
2
﹤0.01% 2880
2018
Q4
$26K Hold
2
﹤0.01% 2996
2018
Q3
$63K Buy
2
+1
+100% +$30.9K ﹤0.01% 3014
2018
Q2
$34K Hold
1
﹤0.01% 3026
2018
Q1
$154K Buy
+1
New +$122K ﹤0.01% 2413

Other funds holding YARW

American International Group's YARW Position: Q2 2021 in Review

American International Group sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q2 2021, closing a stake of 24 shares — an estimated $145 sold.

American International Group first reported a position in YARW in Q1 2018 and held it in 13 quarters. The position peaked at $154K in Q1 2018. 63 funds tracked by Wall St. Rank hold YARW as of Q2 2021.

  • American International Group reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 24 Yarrow Bioscience, Inc. Common Stock shares in Q2 2021, an estimated $145.
  • American International Group first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and held it in 13 quarters.
  • American International Group's Yarrow Bioscience, Inc. Common Stock position peaked at $154K in Q1 2018.
  • 63 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.